HyperMed, Inc. Garners $4,000,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dbc79e96-3975-43c5-9fb5-878a10932222&Preview=1 -
Date
5/23/2008 -
Company Name
HyperMed, Inc. -
Mailing Address
305 Second Avenue Waltham, MA 02451 -
Company Description
HyperMed, Inc., the leader in applying hyperspectral technology to medical applications. HyperMed’s flagship diagnostic device, OxyVu-1™, received U.S. Food and Drug Administration (FDA) clearance in November, 2006 for use in assessing patients for poor tissue circulation including those with diabetic foot ulcers, leg pain or other symptoms of poor blood flow. -
Website
http://www.hypermed-inc.com -
Transaction Type
Venture Equity -
Transaction Amount
$4,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds will support ongoing marketing and sales of OxyVu, its lead product. -
M&A Terms
-
Venture Investor
GBP Capital
